vs
Side-by-side financial comparison of READING INTERNATIONAL INC (RDI) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $39.6M, roughly 1.3× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -5.1%, a 41.0% gap on every dollar of revenue. On growth, SBC Medical Group Holdings Inc posted the faster year-over-year revenue change (-10.9% vs -14.2%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $4.1M). Over the past eight quarters, READING INTERNATIONAL INC's revenue compounded faster (5.6% CAGR vs -15.0%).
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
RDI vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.3M | $39.6M |
| Net Profit | $-2.6M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | -1.9% | 32.5% |
| Net Margin | -5.1% | 35.9% |
| Revenue YoY | -14.2% | -10.9% |
| Net Profit YoY | -14.5% | 117.2% |
| EPS (diluted) | $-0.11 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.3M | $39.6M | ||
| Q3 25 | $52.2M | $43.4M | ||
| Q2 25 | $60.4M | $43.4M | ||
| Q1 25 | $40.2M | $47.3M | ||
| Q4 24 | $58.6M | $44.4M | ||
| Q3 24 | $60.1M | $53.1M | ||
| Q2 24 | $46.8M | $53.1M | ||
| Q1 24 | $45.1M | $54.8M |
| Q4 25 | $-2.6M | $14.2M | ||
| Q3 25 | $-4.2M | $12.8M | ||
| Q2 25 | $-2.7M | $2.5M | ||
| Q1 25 | $-4.8M | $21.5M | ||
| Q4 24 | $-2.2M | $6.5M | ||
| Q3 24 | $-7.0M | $2.8M | ||
| Q2 24 | $-12.8M | $18.5M | ||
| Q1 24 | $-13.2M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | -1.9% | 32.5% | ||
| Q3 25 | -0.6% | 36.6% | ||
| Q2 25 | 4.8% | 33.6% | ||
| Q1 25 | -17.2% | 51.1% | ||
| Q4 24 | 2.6% | 10.6% | ||
| Q3 24 | -0.6% | 26.1% | ||
| Q2 24 | -16.4% | 51.4% | ||
| Q1 24 | -16.7% | 44.6% |
| Q4 25 | -5.1% | 35.9% | ||
| Q3 25 | -8.0% | 29.6% | ||
| Q2 25 | -4.4% | 5.7% | ||
| Q1 25 | -11.8% | 45.4% | ||
| Q4 24 | -3.8% | 14.7% | ||
| Q3 24 | -11.7% | 5.3% | ||
| Q2 24 | -27.4% | 34.8% | ||
| Q1 24 | -29.4% | 34.2% |
| Q4 25 | $-0.11 | $0.15 | ||
| Q3 25 | $-0.18 | $0.12 | ||
| Q2 25 | $-0.12 | $0.02 | ||
| Q1 25 | $-0.21 | $0.21 | ||
| Q4 24 | $-0.11 | $0.05 | ||
| Q3 24 | $-0.31 | $0.03 | ||
| Q2 24 | $-0.57 | $0.20 | ||
| Q1 24 | $-0.59 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.5M | $164.1M |
| Total DebtLower is stronger | $185.1M | $42.8M |
| Stockholders' EquityBook value | $-18.2M | $248.3M |
| Total Assets | $434.9M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.5M | $164.1M | ||
| Q3 25 | $8.1M | $127.4M | ||
| Q2 25 | $9.1M | $152.7M | ||
| Q1 25 | $5.9M | $132.1M | ||
| Q4 24 | $12.4M | $125.0M | ||
| Q3 24 | $10.1M | $137.4M | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $7.5M | — |
| Q4 25 | $185.1M | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | $202.7M | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-18.2M | $248.3M | ||
| Q3 25 | $-12.1M | $248.0M | ||
| Q2 25 | $-7.7M | $244.6M | ||
| Q1 25 | $-8.1M | $226.4M | ||
| Q4 24 | $-4.4M | $195.1M | ||
| Q3 24 | $1.6M | $205.0M | ||
| Q2 24 | $6.5M | $8.8M | ||
| Q1 24 | $18.0M | $9.0M |
| Q4 25 | $434.9M | $380.4M | ||
| Q3 25 | $435.2M | $321.4M | ||
| Q2 25 | $438.1M | $315.3M | ||
| Q1 25 | $441.0M | $284.6M | ||
| Q4 24 | $471.0M | $266.1M | ||
| Q3 24 | $495.7M | $296.5M | ||
| Q2 24 | $494.9M | $19.5M | ||
| Q1 24 | $494.9M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.3M | $52.0M |
| Free Cash FlowOCF − Capex | $4.1M | $51.2M |
| FCF MarginFCF / Revenue | 8.2% | 129.3% |
| Capex IntensityCapex / Revenue | 0.3% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-2.9M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.3M | $52.0M | ||
| Q3 25 | $295.0K | $-20.9M | ||
| Q2 25 | $1.6M | $-8.3M | ||
| Q1 25 | $-7.7M | $1.9M | ||
| Q4 24 | $8.0M | $-7.3M | ||
| Q3 24 | $1.3M | $5.0M | ||
| Q2 24 | $-10.4M | $19.2M | ||
| Q1 24 | $-2.8M | $3.7M |
| Q4 25 | $4.1M | $51.2M | ||
| Q3 25 | $-246.0K | $-20.9M | ||
| Q2 25 | $1.2M | $-8.6M | ||
| Q1 25 | $-8.0M | $1.7M | ||
| Q4 24 | $7.0M | $-7.9M | ||
| Q3 24 | $-1.1M | $4.6M | ||
| Q2 24 | $-10.6M | $18.3M | ||
| Q1 24 | $-4.7M | $3.0M |
| Q4 25 | 8.2% | 129.3% | ||
| Q3 25 | -0.5% | -48.3% | ||
| Q2 25 | 1.9% | -19.9% | ||
| Q1 25 | -19.8% | 3.5% | ||
| Q4 24 | 12.0% | -17.8% | ||
| Q3 24 | -1.8% | 8.7% | ||
| Q2 24 | -22.7% | 34.5% | ||
| Q1 24 | -10.4% | 5.4% |
| Q4 25 | 0.3% | 2.0% | ||
| Q3 25 | 1.0% | 0.1% | ||
| Q2 25 | 0.6% | 0.7% | ||
| Q1 25 | 0.6% | 0.5% | ||
| Q4 24 | 1.7% | 1.3% | ||
| Q3 24 | 4.0% | 0.8% | ||
| Q2 24 | 0.5% | 1.6% | ||
| Q1 24 | 4.3% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
